Functional graphene derivatives for chemotherapy-based synergistic tumor therapy

Xinyu Cui, Wenlong Cheng, Weili Xu, Wei Mu, Xiaojun Han

Research output: Contribution to journalArticleOtherpeer-review

4 Citations (Scopus)


Starting from simplex drug delivery system, the graphene oxide (GO) and reduced GO (rGO) materials have been developed to be "combo" nanoplatforms containing multiple therapeutic modalities, such as the targeted drug delivery, imaging, as well as photothermal therapy (PTT) due to their distinctive physical/chemical and optical properties including excellent biocompatibility, modifiable active groups, ultra-large surface area, and intense photothermal effect. The graphene-based nanoplatforms were used for the stimuli-responsive nanocarriers, showing excellent therapeutic effects activated by endogenous stimuli including low pH, overexpressed enzymes, biomolecules, elevated glutathione, and exogenous stimuli including light, magnetic/electric field, and ultrasound. More importantly, for multimodal synergistic therapy originated from the enhanced collaborative interactions among several monotherapy types, the obtained remarkable super-additive effects were not the results just through single therapy or their theoretical combination. In this review, the recent progresses of smart graphene-based nanoplatforms for integrated cancer therapy and bio-imaging are presented. Current challenges and future perspectives of graphene-based nanoplatforms in the biomedical field are also discussed.

Original languageEnglish
Article number1930006
Number of pages19
Issue number11
Publication statusPublished - Nov 2019


  • drug delivery
  • Graphene-based nanomaterials
  • synergistic therapy
  • theranostics

Cite this